CD14 and ovarian neoplasm: It will be important to determine whether STAT3 phosphorylation correlates with PD-L1 expression, and further determine whether treatment of ovarian tumor ascites CD14+ cells with small molecule inhibitors of STAT3 leads to reduced PD-L1 expression.